Annual Secretarial Compliance Report for the financial year ended March 31, 2026.
NOVARTIND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Novartis India Limited has submitted its Annual Secretarial Compliance Report for FY 2025-26, certified by practicing company secretaries M K Saraf & Associates LLP. The report examines compliance with SEBI regulations including LODR 2015, Insider Trading Regulations, and other applicable securities laws. The company has declared full compliance across all 13 checkpoints covering secretarial standards, board evaluations, related party transactions, website disclosures, director disqualifications, and preservation of documents. No deviations, violations, or penalties were reported. No actions were taken by SEBI or stock exchanges against the company, its promoters, or directors during the review period.
Clean compliance report indicates strong corporate governance adherence. No red flags for investors. The company has no material subsidiaries and all regulatory requirements were met during FY 2025-26.